Keywords: Cetuximab, Epidermal Growth Factor Receptor, Lapatinib, Protein Tyrosine Kinase, Saracatinib, Trastuzumab, Animal Experiment, Animal Model, Antineoplastic Activity, Article, Breast Cancer, Breast Cancer Cell Line, Cancer Inhibition, Cancer Resistance, Cell Invasion, Cell Migration, Cell Proliferation, Cell Survival, Controlled Study, Drug Efficacy, Drug Sensitivity, Enzyme Activation, Enzyme Inhibition, Enzyme Linked Immunosorbent Assay, Female, Human, Human Cell, Immunoprecipitation, In Vitro Study, In Vivo Study, Mouse, Nonhuman, Signal Transduction, Treatment Duration, Tumor Invasion, Western Blotting, Wound Healing,
Affiliations: *** IBB - CNR ***
Departments of Medicina Clinica e Chirurgia, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
Istituto di Biostrutture e Bioimmagini, CNR, Via Pietro Castellino 111, 80131 Naples, Italy
Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
Sanità Pubblica, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
Medicina Molecolare e Biotecnologie Mediche, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
Department of Microbiology, Immunology and Cancer Biology, Cancer Center, University of Virginia Health System, Charlottesville, Virginia 22908, United States
Sanit Pubblica, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy
References: Not available.
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(423 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote